Gastric Cancer in Europe 2018: Epidemiology, Patient Flow, Prevalence and Diagnosed & Treated Patient Analysis (2017-2026) - ResearchAndMarkets.com

July 5, 2018

DUBLIN--(BUSINESS WIRE)--Jul 5, 2018--The “Europe Gastric Cancer Epidemiology and Patient Flow Analysis - 2018” report has been added to ResearchAndMarkets.com’s offering.

This research provides insights into Gastric Cancer epidemiology, Gastric Cancer diagnosed patients, and Gastric Cancer treatment rate for EU5 countries. The research measures key indicators including prevalence of Gastric Cancer derived from epidemiological analysis, patients diagnosed with Gastric Cancer, and patients treated with a drug therapy.

The research study helps executives estimate Gastric Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Gastric Cancer prevalence, Gastric Cancer diagnosis rate, and Gastric Cancer treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Topics Covered

1. Gastric Cancer Disease Definition

2. Gastric Cancer Patient Flow in Europe

3. Gastric Cancer Patient Flow in Germany

4. Gastric Cancer Patient Flow in France

5. Gastric Cancer Patient Flow in Spain

6. Gastric Cancer Patient Flow in Italy

7. Gastric Cancer Patient Flow in UK

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/6gpmdh/gastric_cancer_in?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180705005493/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/05/2018 01:47 PM/DISC: 07/05/2018 01:48 PM


Update hourly